Clinical Trials Browser

Phase 1/2 × Recurrence × tagraxofusp × Clear all

NCT02661022 2024-04-17

SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Phase 1/2 Terminated

9 enrolled 13 charts

Multiple Myeloma, Recurrence